421 related articles for article (PubMed ID: 20035998)
1. A molecular receptor targeted, hydroxyapatite nanocrystal based multi-modal contrast agent.
Ashokan A; Menon D; Nair S; Koyakutty M
Biomaterials; 2010 Mar; 31(9):2606-16. PubMed ID: 20035998
[TBL] [Abstract][Full Text] [Related]
2. Folate receptor targeted, rare-earth oxide nanocrystals for bi-modal fluorescence and magnetic imaging of cancer cells.
Setua S; Menon D; Asok A; Nair S; Koyakutty M
Biomaterials; 2010 Feb; 31(4):714-29. PubMed ID: 19822364
[TBL] [Abstract][Full Text] [Related]
3. Molecular-receptor-specific, non-toxic, near-infrared-emitting Au cluster-protein nanoconjugates for targeted cancer imaging.
Retnakumari A; Setua S; Menon D; Ravindran P; Muhammed H; Pradeep T; Nair S; Koyakutty M
Nanotechnology; 2010 Feb; 21(5):055103. PubMed ID: 20023317
[TBL] [Abstract][Full Text] [Related]
4. Bio-conjugated luminescent quantum dots of doped ZnS: a cyto-friendly system for targeted cancer imaging.
Manzoor K; Johny S; Thomas D; Setua S; Menon D; Nair S
Nanotechnology; 2009 Feb; 20(6):065102. PubMed ID: 19417370
[TBL] [Abstract][Full Text] [Related]
5. Development and haematotoxicological evaluation of doped hydroxyapatite based multimodal nanocontrast agent for near-infrared, magnetic resonance and X-ray contrast imaging.
Ashokan A; Chandran P; Sadanandan AR; Koduri CK; Retnakumari AP; Menon D; Nair S; Koyakutty M
Nanotoxicology; 2012 Sep; 6(6):652-66. PubMed ID: 21780855
[TBL] [Abstract][Full Text] [Related]
6. Folate targeted polymeric 'green' nanotherapy for cancer.
Narayanan S; Binulal NS; Mony U; Manzoor K; Nair S; Menon D
Nanotechnology; 2010 Jul; 21(28):285107. PubMed ID: 20585151
[TBL] [Abstract][Full Text] [Related]
7. Folate-mediated tumor cell uptake of quantum dots entrapped in lipid nanoparticles.
Schroeder JE; Shweky I; Shmeeda H; Banin U; Gabizon A
J Control Release; 2007 Dec; 124(1-2):28-34. PubMed ID: 17928088
[TBL] [Abstract][Full Text] [Related]
8. Folic acid-Pluronic F127 magnetic nanoparticle clusters for combined targeting, diagnosis, and therapy applications.
Lin JJ; Chen JS; Huang SJ; Ko JH; Wang YM; Chen TL; Wang LF
Biomaterials; 2009 Oct; 30(28):5114-24. PubMed ID: 19560199
[TBL] [Abstract][Full Text] [Related]
9. Dual-modality in vivo imaging using rare-earth nanocrystals with near-infrared to near-infrared (NIR-to-NIR) upconversion luminescence and magnetic resonance properties.
Zhou J; Sun Y; Du X; Xiong L; Hu H; Li F
Biomaterials; 2010 Apr; 31(12):3287-95. PubMed ID: 20132982
[TBL] [Abstract][Full Text] [Related]
10. Targeted folic acid-PEG nanoparticles for noninvasive imaging of folate receptor by MRI.
Chen TJ; Cheng TH; Hung YC; Lin KT; Liu GC; Wang YM
J Biomed Mater Res A; 2008 Oct; 87(1):165-75. PubMed ID: 18085650
[TBL] [Abstract][Full Text] [Related]
11. Enhanced tumor detection using a folate receptor-targeted near-infrared fluorochrome conjugate.
Moon WK; Lin Y; O'Loughlin T; Tang Y; Kim DE; Weissleder R; Tung CH
Bioconjug Chem; 2003; 14(3):539-45. PubMed ID: 12757377
[TBL] [Abstract][Full Text] [Related]
12. [Folate-poly-L-lysine-Gd-DTPA as MR contrast agent for tumor imaging via folate receptor-targeted delivery].
Yuan Z; Liu SY; Xiao XS; Zhong GR; Jiang QJ
Zhonghua Yi Xue Za Zhi; 2007 Mar; 87(10):673-8. PubMed ID: 17553304
[TBL] [Abstract][Full Text] [Related]
13. Highly biocompatible TiO₂:Gd³⁺ nano-contrast agent with enhanced longitudinal relaxivity for targeted cancer imaging.
Chandran P; Sasidharan A; Ashokan A; Menon D; Nair S; Koyakutty M
Nanoscale; 2011 Oct; 3(10):4150-61. PubMed ID: 21853215
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and characterization of PEGylated Gd2O3 nanoparticles for MRI contrast enhancement.
Ahrén M; Selegård L; Klasson A; Söderlind F; Abrikossova N; Skoglund C; Bengtsson T; Engström M; Käll PO; Uvdal K
Langmuir; 2010 Apr; 26(8):5753-62. PubMed ID: 20334417
[TBL] [Abstract][Full Text] [Related]
15. Targeted dual-contrast T1- and T2-weighted magnetic resonance imaging of tumors using multifunctional gadolinium-labeled superparamagnetic iron oxide nanoparticles.
Yang H; Zhuang Y; Sun Y; Dai A; Shi X; Wu D; Li F; Hu H; Yang S
Biomaterials; 2011 Jul; 32(20):4584-93. PubMed ID: 21458063
[TBL] [Abstract][Full Text] [Related]
16. Efficient delivery of an antisense oligodeoxyribonucleotide formulated in folate receptor-targeted liposomes.
Chiu SJ; Marcucci G; Lee RJ
Anticancer Res; 2006; 26(2A):1049-56. PubMed ID: 16619505
[TBL] [Abstract][Full Text] [Related]
17. Folate receptor targeted, carboxymethyl chitosan functionalized iron oxide nanoparticles: a novel ultradispersed nanoconjugates for bimodal imaging.
Bhattacharya D; Das M; Mishra D; Banerjee I; Sahu SK; Maiti TK; Pramanik P
Nanoscale; 2011 Apr; 3(4):1653-62. PubMed ID: 21331392
[TBL] [Abstract][Full Text] [Related]
18. Paramagnetic ultrasmall gadolinium oxide nanoparticles as advanced T1 MRI contrast agent: account for large longitudinal relaxivity, optimal particle diameter, and in vivo T1 MR images.
Park JY; Baek MJ; Choi ES; Woo S; Kim JH; Kim TJ; Jung JC; Chae KS; Chang Y; Lee GH
ACS Nano; 2009 Nov; 3(11):3663-9. PubMed ID: 19835389
[TBL] [Abstract][Full Text] [Related]
19. Blood compatibility of iron-doped nanosize hydroxyapatite and its drug release.
Chandra VS; Baskar G; Suganthi RV; Elayaraja K; Joshy MI; Beaula WS; Mythili R; Venkatraman G; Kalkura SN
ACS Appl Mater Interfaces; 2012 Mar; 4(3):1200-10. PubMed ID: 22316071
[TBL] [Abstract][Full Text] [Related]
20. Properties evaluation of a new MRI contrast agent based on Gd-loaded nanoparticles.
Riyahi-Alam N; Behrouzkia Z; Seifalian A; Haghgoo Jahromi S
Biol Trace Elem Res; 2010 Dec; 137(3):324-34. PubMed ID: 20049554
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
